Drug persistence is similar with rivastigmine and donepezil in Alzheimer's disease patients

被引：0

作者：

Mauskopf, J

Paramore, C

Lee, WC

McBurney, CR

Snyder, EH

机构：

[1] Res Triangle Inst, Chapel Hill, NC USA

[2] MEDTAP Int, Bethesda, MD USA

[3] Abt Associates Inc, Bethesda, MD USA

[4] Novartis Pharmaceut, E Hanover, NJ USA

来源：

NEUROBIOLOGY OF AGING | 2004年 / 25卷

关键词：

D O I：

10.1016/S0197-4580(04)80685-7

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

引用

页码：S204 / S204

页数：1

共 50 条

[41] A RAPID REVIEW OF ECONOMIC EVALAUTIONS OF DONEPEZIL, RIVASTIGMINE, GALANTAMINE AND MEMANTINE FOR ALZHEIMER'S DISEASE (AD)
Feng, J.
Huang, R.
Pwee, K.
VALUE IN HEALTH, 2010, 13 (07) : A560 - A560
[42] Lack of significant drug-drug interactions with aceylcholonesterase inhibitor rivastigmine in Alzheimer's Disease patients
Grossberg, GT
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (09) : S63 - S63
[43] SWAP: the safety and tolerability of switching oral donepezil to rivastigmine patch in Alzheimer's disease (AD)
Eagle, G.
Alva, G.
Farlow, M.
Sadowsky, C.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2008, 56 (04) : S77 - S77
[44] The cost-effectiveness of donepezil and rivastigmine in the treatment of Alzheimer's disease in Thailand private hospital
Pattanaprateep, O
Phongchareonsuk, P
Chaikledkaew, U
VALUE IN HEALTH, 2005, 8 (03) : 314 - 315
[45] Safety and Tolerability of Donepezil, Rivastigmine and Galantamine for Patients with Alzheimer's Disease: Systematic Review of the 'Real-World' Evidence
Lockhart, I. A.
Mitchell, S. A.
Kelly, S.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2009, 28 (05) : 389 - 403
[46] Rivastigmine can stabilize cognitive and behavioral decline in patients with probable Alzheimer's disease who worsen on donepezil treatment
Edwards, K
O'Connor, J
Button, J
Goodman, W
Norton, J
NEUROBIOLOGY OF AGING, 2002, 23 (01) : S79 - S79
[47] Rivastigmine can stabilize cognitive and behavioral decline in patients with probable Alzheimer's disease who worsen on donepezil treatment
Edwards, KR
O'Connor, J
Button, J
Goodman, WA
Norton, J
INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 254 - 255
[48] Sex and ESR1 genotype may influence the response to treatment with donepezil and rivastigmine in patients with Alzheimer's disease
Scacchi, Renato
Gambina, Giuseppe
Broggio, Elisabetta
Corbo, Rosa Maria
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2014, 29 (06) : 610 - 615
[49] Response to comments on Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil
Auriacombe, S
Pere, JJ
CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (06) : IV - VI
[50] A multinational, randomised, 12-week, comparative study of donepezil and rivastigmine in patients with mild to moderate Alzheimer's disease
Wilkinson, DG
Passmore, AP
Bullock, R
Hopker, SW
Smith, R
Potocnik, FCV
Maud, CM
Engelbrecht, I
Hock, C
Ieni, JR
Bahra, RS
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, 56 (06) : 441 - 446

← 1 2 3 4 5 →